ADVENZYMES — Advanced Enzyme Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹36.89bn
- IN₹31.80bn
- IN₹6.37bn
- 96
- 25
- 36
- 54
Annual cashflow statement for Advanced Enzyme Technologies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | C2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2,104 | 1,711 | 1,404 | 1,878 | 1,874 |
| Depreciation | |||||
| Non-Cash Items | -41.5 | -18.2 | 19.3 | -62.1 | -95.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -711 | -819 | -370 | -755 | -719 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,635 | 1,223 | 1,404 | 1,414 | 1,425 |
| Capital Expenditures | -194 | -281 | -381 | -423 | -338 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -65.9 | 243 | -2,601 | -223 | -553 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -260 | -37.9 | -2,982 | -646 | -891 |
| Financing Cash Flow Items | -15.4 | -229 | -92.2 | -85.3 | -33.4 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -263 | -485 | -258 | -592 | -725 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,093 | 754 | -1,709 | 173 | -195 |